Literature DB >> 8013085

Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury.

J P Guo1, K A Milhoan, R S Tuan, A M Lefer.   

Abstract

We studied the effects of an organic nitric oxide (NO) donor SPM-5185 in a rat carotid artery intimal injury model. Seven days after injury, the two end segments of the injured carotid arteries were studied for endothelial release of NO, and the middle segments were used for histological measurement of the intimal-to-medial (I/M) ratio and scanning electron microscopy of the luminal surface. The NO donor SPM-5185 or its non-NO-donating control compound SPM-5267 were infused intravenously at 30 micrograms/d. Full vasorelaxant responses of rat carotid arterial rings were obtained with the endothelium-dependent vasodilators acetylcholine (ACh), A23187, and the endothelium-independent vasodilator acidified NaNO2 in sham-operated control rings. Impaired relaxation occurred with 10 mumol/L ACh and 1 mumol/L A23187 in injured rings but not in rings infused with SPM-5185 for 7 days. Relaxation to 100 mumol/L acidified NaNO2 was not significantly different among any of the groups, indicating a normal vascular smooth muscle response after intimal injury. Morphometric analysis of injured carotid arteries given vehicle and SPM-5267 showed marked intimal thickening with an average I/M ratio of 0.78 +/- 0.03 and 0.74 +/- 0.05, respectively. SPM-5185 markedly attenuated intimal thickening, resulting in an I/M ratio of 0.13 +/- 0.03 (P < .01 from vehicle), representing an approximately 82% inhibition of intimal thickening. SPM-5185 infusion resulted in accelerated regeneration of endothelial cells on the intimal surface at 7 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013085     DOI: 10.1161/01.res.75.1.77

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression.

Authors:  N Kronemann; W A Nockher; R Busse; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

Authors:  L L Shears; N Kawaharada; E Tzeng; T R Billiar; S C Watkins; I Kovesdi; A Lizonova; S M Pham
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

4.  The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis.

Authors:  A Hacker; S Müller; W Meyer; G Kojda
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Dietary copper supplements modulate aortic superoxide dismutase, nitric oxide and atherosclerosis.

Authors:  David J Lamb; Michelle L Tickner; Susanna M O Hourani; Gordon A A Ferns
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

6.  Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts.

Authors:  L M Akyürek; B C Fellström; Z Q Yan; G K Hansson; K Funa; E Larsson
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 7.  The role of nitric oxide in cardiac surgery.

Authors:  Y Nonami
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

8.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.